Pages that link to "Q44780583"
Jump to navigation
Jump to search
The following pages link to Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. (Q44780583):
Displaying 50 items.
- Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer (Q24187473) (← links)
- Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer (Q24201198) (← links)
- Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis (Q24240382) (← links)
- Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix (Q24246593) (← links)
- Extended-field irradiation for locally advanced cervical cancer (Q26471206) (← links)
- Concurrent chemoradiation for high-risk prostate cancer (Q26798912) (← links)
- The role of intensity modulated radiotherapy in gynecological radiotherapy: Present and future (Q26829528) (← links)
- Human papillomavirus induced transformation in cervical and head and neck cancers (Q27003141) (← links)
- A practical review of magnetic resonance imaging for the evaluation and management of cervical cancer (Q28072331) (← links)
- University Cooperation Platform (UCP) between Christian-Albrechts-University Kiel (Germany) and Chiang Mai University (Thailand): implementation of image-guided gynecological brachytherapy (Q28083557) (← links)
- Expression of epidermal growth factor‑like domain 7 may be a predictive marker of the effect of neoadjuvant chemotherapy for locally advanced uterine cervical cancer (Q28468344) (← links)
- Matrix metalloproteinase-8 mediates the unfavorable systemic impact of local irradiation on pharmacokinetics of anti-cancer drug 5-Fluorouracil (Q28478505) (← links)
- Does para-aortic irradiation reduce the risk of distant metastasis in advanced cervical cancer? A systematic review and meta-analysis of randomized clinical trials (Q30240279) (← links)
- Detection of metastatic tumors after γ-irradiation using longitudinal molecular imaging and gene expression profiling of metastatic tumor nodules (Q30388141) (← links)
- Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial (Q30440940) (← links)
- Radiation-induced tumor neoantigens: imaging and therapeutic implications. (Q30473856) (← links)
- The use of healing touch in integrative oncology (Q30570204) (← links)
- Quantification of delineation errors of the gross tumor volume on magnetic resonance imaging in uterine cervical cancer using pathology data and deformation correction (Q30872622) (← links)
- Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: A National Cancer Data Base (NCDB) analysis (Q30930781) (← links)
- Concurrent chemoradiotherapy for cervical cancer: background including evidence-based data, pitfalls of the data, limitation of treatment in certain groups (Q31097553) (← links)
- EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: implications for targeted radiotherapy (Q33359764) (← links)
- Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer (Q33364078) (← links)
- Phase one dose finding study of capecitabine (Xeloda), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer (Q33366314) (← links)
- Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials (Q33383729) (← links)
- Whole pelvic helical tomotherapy for locally advanced cervical cancer: technical implementation of IMRT with helical tomotherapy (Q33387475) (← links)
- Radiation therapy with chemotherapy for patients with cervical cancer and supraclavicular lymph node involvement (Q33402414) (← links)
- A randomized trial comparing concurrent chemoradiotherapy with single-agent cisplatin versus cisplatin plus gemcitabine in patients with advanced cervical cancer: An Asian Gynecologic Oncology Group study. (Q33421615) (← links)
- A short time interval between radiotherapy and hyperthermia reduces in-field recurrence and mortality in women with advanced cervical cancer (Q33612828) (← links)
- Keratin 17 in premalignant and malignant squamous lesions of the cervix: proteomic discovery and immunohistochemical validation as a diagnostic and prognostic biomarker (Q33634684) (← links)
- The Role of (18) F-FDG PET/CT in Assessing Therapy Response in Cervix Cancer after Concurrent Chemoradiation Therapy (Q33639390) (← links)
- Translating response during therapy into ultimate treatment outcome: a personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancer (Q33672588) (← links)
- Clinical potential of bevacizumab in the treatment of metastatic and locally advanced cervical cancer: current evidence (Q33680243) (← links)
- Aurora-A affects radiosenstivity in cervical squamous cell carcinoma and predicts poor prognosis (Q33761806) (← links)
- Stereotactic body radiotherapy (SBRT): Technological innovation and application in gynecologic oncology. (Q33782847) (← links)
- Assessment of local treatment modalities for FIGO stage IB-IIB cervical cancer: A propensity-score matched analysis based on SEER database (Q33784461) (← links)
- Timing of cisplatin administration for chemoradiotherapy in transgenic mice bearing lens tumors (Q33793959) (← links)
- Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. (Q34009168) (← links)
- Successful Treatment of Primary Vaginal Papillary Serous Adenocarcinoma Using Chemoradiation Followed by Brachytherapy (Q34054784) (← links)
- Concurrent Chemoradiotherapy without Brachytherapy in Locally Advanced Cervical Cancer. (Q34082463) (← links)
- Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer. (Q34123402) (← links)
- Posttherapy residual disease associates with long-term survival after chemoradiation for bulky stage 1B cervical carcinoma: a Gynecologic Oncology Group study (Q34163791) (← links)
- Is extended-field concurrent chemoradiation an option for radiologic negative paraaortic lymph node, locally advanced cervical cancer? (Q34180901) (← links)
- A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer (Q34202723) (← links)
- Sequential magnetic resonance imaging of cervical cancer: the predictive value of absolute tumor volume and regression ratio measured before, during, and after radiation therapy (Q34217653) (← links)
- Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: A Southwest Oncology Group Study (Q34298822) (← links)
- Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach. (Q34441128) (← links)
- Molecular Strategies of Deoxynucleotide Triphosphate Supply Inhibition Used in the Treatment of Gynecologic Malignancies (Q34482362) (← links)
- Impact of age on morbidity and outcome of concurrent radiochemotherapy in high-risk FIGO stage I to IVA carcinoma of the uterine cervix following laparoscopic surgery (Q34565204) (← links)
- Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study. (Q34646432) (← links)
- Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers (Q34662652) (← links)